Pancreatic DiseaseDiagnostics and screeningGut healthCancerDevice
What this study is
This is a randomized trial to compare the standard echoendoscope with the newly developed EndoSound Visual System in the evaluation of lesions in the gastrointestinal tract.
What's being tested
- Endoscopic ultrasound examination
Intervention · DEVICE
Endoscopic ultrasound examination will be performed.
Study details
- Official title
- Randomized Trial of Endoscopic Ultrasound Examination Using EndoSound Vision System vs. Standard Echoendoscope
- Sponsor
- Orlando Health, Inc.
- Conditions
- Pancreatic Disease · Pancreatic Cancer · Pancreatic Cyst · Gastrointestinal Tumor · Bile Duct Diseases · Bile Duct Cancer · Lymph Node Disease · Submucosal Tumor of Gastrointestinal Tract · Gastrointestinal Cancer
- Enrolling
- 140 people
- Starts
- 2026-10
- Est. completion
- 2028-12
- Design
- Triple-blind, randomized, crossover
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 100 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age ≥ 18 years
- Any patient undergoing EUS examination for evaluation of the pancreas, bile duct, mediastinal or intraabdominal lymph nodes, or luminal lesions in the esophagus, stomach, duodenum or colon.
You can't join if
- Age < 18 years.
- Unable to obtain consent for the procedure from either the patient or LAR.
- Intrauterine pregnancy.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openOrlando Health
Orlando, Florida, United States
- Ji Young Bang, MD MPH · Contact321-841-2431jiyoung.bang@orlandohealth.com
- Barbara Broome · Contact321-841-4356barbara.broome@orlandohealth.com
Recruiting
Study team
Sponsor
Orlando Health, Inc.
Study ID 24.017.01
Principal investigator
Ji Young Bang, MD MPH
Orlando Health, Digestive Health Institute
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.